High-Order Hazard Functions and Treatment Choice

Appelbaum, Elie and Prisman, Eliezer, Z. (2025): High-Order Hazard Functions and Treatment Choice.

Abstract

Hazard function applications in medical research are problematic for two reasons. First, they are not cast within a decision theory framework. Second, they often adopt severe self-imposed restrictive structures (e.g., in the constant hazard ratio models). The disadvantage of an excessively restrictive structure is self-evident. The disadvantage of the lack of a theoretical basis, which is more subtle, is that treatment choice itself becomes unnecessarily restrictive because decision theory insights remain untapped. This paper uses a decision-theory-based framework for treatment choice, thus addressing the two issues above. It shows that high-order stochastic dominance tools, in conjunction with risk preference attributes, can often be used to compare treatments under weaker conditions than the ones currently used. The paper compares treatments by using what we call high-order hazard functions. These high-order hazard functions are obtained by calculating areas under low-order hazard functions (such as standard and cumulative hazard functions). The paper provides necessary and sufficient conditions for treatment comparisons based on these high-order hazard functions. These conditions are shown to be weaker than the ones currently used because we are able to exploit theoretical tools that are otherwise unavailable. Thus, for example, it shows that our framework often allows treatment comparisons even when hazard functions cross. An example using real-world data shows that the use of high-order stochastic dominance and risk preference attributes allows us to identify a preferred treatment even if low-order hazard functions cross.

• Item Type: MPRA Paper
• Language: English
• Keywords: High-Order Hazard Functions, Treatment Choice, Survival Functions, High-Order Stochastic Dominance, Risk Preferences.
• Subjects: C - Mathematical and Quantitative Methods > C1 - Econometric and Statistical Methods and Methodology: General > C18 - Methodological Issues: General; C - Mathematical and Quantitative Methods > C6 - Mathematical Methods ; Programming Models ; Mathematical and Simulation Modeling > C65 - Miscellaneous Mathematical Tools; D - Microeconomics > D8 - Information, Knowledge, and Uncertainty > D81 - Criteria for Decision-Making under Risk and Uncertainty; I - Health, Education, and Welfare > I0 - General; I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior; I - Health, Education, and Welfare > I1 - Health > I19 - Other

References

Appelbaum, E., Leshno, M., Prisman, E. and E.Z. Prisman, (2024), "Stochastic Dominance, Risk Attributes and Crossing, Kaplan-Meier Curves," Discussion paper.

Austin, P.C., Fang J, and DS. Lee, (2022), "Using fractional polynomials and restricted cubic splines to model non-proportional hazards or time-varying covariate effects in the Cox regression model," Statistics in Medicine, 41, 3, 612--624. doi:10.1002/sim.9259.

Arenal, A., et al. (2022). "Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia." J Am Coll Cardiol 79(15): 1441-1453.

Attemaa, A.E., l'Haridonb, O., et al., (2019), "Measuring multivariate risk preferences in the health domain," Journal of Health Economics 64, 15-24.

Berridge, C, and M.L. Kringelbach, (2015), "Pleasure Systems in the Brain," Neuron, 86, 3, 646-664. DOI:https://doi.org/10.1016/j.neuron.2015.02.018.

Colasante, A. and L. Riccetti, (2020), "Risk aversion, prudence and temperance: It is a matter of gap between moments," Journal of Behavioral and Experimental Finance, 25, p.100262.

Courbage, C. and B. Rey, (2012), "Priority setting in health care and higher order degree change in risk," Journal of Health Economics, 31, 484-489.

Cox, D.R., (1972), "Regression Models and Life-Tables," Journal of the Royal Statistical Society, Series B, 34, 2, 187-220.

Crawford, S., (2022), "Evaluating Treatment Options for Metastatic, Castration-Resistant Prostate Cancer: A Comprehensive Value Assessment," Doctoral dissertation, University of Southern California.

Cykert, S., (2004), "Risk acceptance and risk aversion: patients' perspectives on lung surgery," Thoracic surgery clinics, 14, 3, 287-293.

Dai, Jingyi, et al., (2025), "Survival Benefits of Transarterial Chemoembolization Plus Ablation Therapy in Patients With Intermediate or Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study," Cancer Management and Research, 483-497.

Deakin, C.T., Alexander, I.E. and I. Kerridge, (2009), "Accepting Risk in Clinical Research: Is the Gene Therapy Field Becoming Too Risk-averse?" Molecular Therapy, 17, 11, 842-1848, DOI:https://doi.org/10.1038/mt.2009.223.

Deck, C. and H. Schlesinger, (2010), "Exploring higher order risk effects," The Review of Economic Studies, 77, 4, 1403-1420.

Dehbi, H.M., Royston, P. and A. Hackshaw, (2018), "Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards," BMJ, 2017;357:j2250, doi: https://doi.org/10.1136/bmj.j2250.

Dormuth, I., Liu, T., Xu, J. et al., (2022), "Which test for crossing survival curves? A user's guideline." BMC Med Res Methodol 22, 34. https://doi.org/10.1186/s12874-022-01520-0.

Ebert, S., and D. Wiesen, (2011), "Testing for Prudence and Skewness Seeking," Management Science, 57, 7, 1334-1349.

Felder, S. and T Mayrhofer, (2014), "Risk preferences: consequences for test and treatment thresholds and optimal cutoffs," Medical Decision Making 34, 33--41.

Judge, D.P., et al. (2025), "Efficacy of acoramidis on all-cause mortality and cardiovascular hospitalization in transthyretin amyloid cardiomyopathy." Journal of the American College of Cardiology, 85.10, 1003-1014.

Kaplan, E. L. and P. Meier, (1958), "Nonparametric estimation from incomplete observations," Journal of the American Statistical Association, 53, 282, 457-481.

Klein, W. M., and M.E., Stefanek, (2007), "Cancer risk elicitation and communication: lessons from the psychology of risk perception," CA: a cancer journal for clinicians, 57, 3, 147-167.

Kristiansen, I.S., (2012), "PRM39 Survival curve convergences and crossing: a threat to the validity of meta-analysis?," Value in health, 15, 7. A652 10.1016/j.jval.2012.08.290.

Levy, H, (1992), "Stochastic Dominance and Expected Utility: Survey and Analysis," Management Science, 38, 4, 555-593.

Li, H. et al., (2025), "The relationship between hemoglobin, albumin, lymphocyte, and platelet (HALP) score and 28-day mortality in patients with sepsis: a retrospective analysis of the MIMIC-IV database." BMC Infectious Diseases 25,1, 333.

Locey, K. et al. (2024), "Rush regression workbench: An integrated open-source application for regression modeling and analysis in healthcare analytics," Healthcare Analytics, 5, https://doi.org/10.1016/j.health.2024.100314.

Makins, N., (2023), "Patients, doctors and risk attitudes," Journal of Medical Ethics, 49, 11, 737-741.

Mamun, Md.A. et al. (2023), "A machine learning approach for risk factors analysis and survival prediction of heart failure patients," Healthcare Analytics, https://doi.org/10.1016/j.health.2023.100182.

Mobini, S., Chiang, T.J., et al. (2000), "Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: A quantitative analysis," Psychopharmacology, 149, 3, 313--318. doi:10.1007/s002130000385.

Nath, P.G. et al. (2023), "An interactive web-based tool for predicting and exploring brain cancer survivability," Healthcare Analytics, 3, https://doi.org/10.1016/j.health.2022.100132.

Park K.Y. and Qiu P., (2014), Model selection and diagnostics for joint modeling of survival and longitudinal data with crossing hazard rate functions, Statistics in Medicine, 33, 4532--4546. doi: 10.1002/sim.6259.

Riddel, M. and D. Hales, (2018), "Predicting Cancer-Prevention Behavior: Disentangling the Effects of Risk Aversion and Risk Perceptions," Risk Analysis, 38, 10. Rothschild, M. and J. E. Stiglitz, (1 970), "Increasing risk: I. A definition," Journal of Economic Theory, 2, 3, 225-243. https://doi.org/10.1016/0022-0531(70)90038-4.

Schultz, W., (2015), "Neuronal Reward and Decision Signals: From Theories to Data," Physiological Reviews., 95, 3, 853--951. doi:10.1152/physrev.00023.2014

Von Neumann, J. and O. Morgenstern, (1944), Theory of Games and Economic Behavior, Princeton University Press.

Yao, W., Frydman H et al., (2022), "Ensemble methods for survival function estimation with time-varying covariates," Stat Methods Med Res., 31, 11, 2217-2236. doi: 10.1177/09622802221111549.